PRESS RELEASE published on 02/17/2026 at 07:30, 4 months 1 day ago Inside Information / Other news releases Sensorion announces Nawal Ouzren stepping down as CEO for personal reasons. Amit Munshi to serve as Interim CEO. Sanofi-led financing for pipeline assets Leadership Changes Sanofi Sensorion Amit Munshi Nawal Ouzren
BRIEF published on 02/06/2026 at 07:35, 4 months 12 days ago Sensorion participera à la 49e réunion annuelle d'hiver de l'ARO. Biotechnologie Thérapie Génique Sensorion Perte Auditive Réunion ARO
BRIEF published on 02/06/2026 at 07:35, 4 months 12 days ago Sensorion to Participate in ARO 49th Annual Midwinter Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ARO Meeting
PRESS RELEASE published on 02/06/2026 at 07:30, 4 months 12 days ago Informations privilégiées / Autres communiqués Sensorion participe à la 49ème rencontre annuelle de l’ARO pour présenter sa nouvelle thérapie génique SENS-601 pour la surdité autosomique récessive non syndromique 1A Thérapie Génique Sensorion Perte Auditive Surdité ARO
PRESS RELEASE published on 02/06/2026 at 07:30, 4 months 12 days ago Inside Information / Other news releases Sensorion to present SENS-601 gene therapy at ARO 49th Annual Midwinter Meeting in Puerto Rico Gene Therapy Sensorion Hearing Loss SENS-601 ARO 49th Annual Midwinter Meeting
BRIEF published on 01/28/2026 at 07:48, 4 months 21 days ago Sensorion Secures €60 Million Financing to Advance Hearing Loss Therapies Gene Therapy Biotech Financing Sensorion Hearing Loss Sanofi Investment
BRIEF published on 01/28/2026 at 07:48, 4 months 21 days ago Sensorion obtient un financement de 60 millions d'euros pour faire progresser les thérapies contre la perte auditive Thérapie Génique Sensorion Perte Auditive Financement Des Biotechnologies Investissements Sanofi
PRESS RELEASE published on 01/28/2026 at 07:43, 4 months 21 days ago Informations privilégiées / Autres communiqués Sensorion annonce un financement de 60 millions d’euros avec Sanofi et d'autres investisseurs pour développer ses thérapies géniques. Trésorerie prévue jusqu'à mi-2027 Financement Trésorerie Thérapie Génique Sanofi Sensorion
PRESS RELEASE published on 01/28/2026 at 07:43, 4 months 21 days ago Inside Information / Other news releases Sensorion announces €60 million financing with a €20M strategic investment from Sanofi and support from global healthcare specialists to advance genetic medicine pipeline. Cash runway extended until H1 2027 Financing Sanofi Sensorion Genetic Medicine Healthcare Specialists
BRIEF published on 12/19/2025 at 07:35, 5 months 30 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
Published on 06/19/2026 at 04:30, 1 hour 46 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 4 hours 56 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 5 hours 9 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 6 hours 16 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/19/2026 at 06:00, 16 minutes ago Hong Kong universities scale global heights, cementing education hub status
Published on 06/19/2026 at 03:35, 2 hours 41 minutes ago From Father's Day to Summer Getaways: How Oxygen Support Helps Protect Health During Europe's Peak Travel Season
Published on 06/19/2026 at 03:00, 3 hours 16 minutes ago HARDHITTER Showcases Global Leading EV Charging Infrastructure Solutions at Power2Drive Europe 2026
Published on 06/19/2026 at 01:15, 5 hours 1 minute ago UV Laser Technology Gains Momentum in Europe for Clean, Cold Marking and High-Precision Engraving
Published on 06/18/2026 at 22:35, 7 hours 41 minutes ago Bitmine Immersion Technologies Announces Cash Dividend of $0.1056 per Share of 9.50% Series A Perpetual Preferred Stock
Published on 06/18/2026 at 18:00, 12 hours 16 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mai 2026
Published on 06/18/2026 at 18:00, 12 hours 16 minutes ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 12 hours 31 minutes ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:45, 12 hours 31 minutes ago EURAZEO INVESTIT DANS LAURALU, ACTEUR PANEUROPÉEN SPÉCIALISTE DES INFRASTRUCTURES INDUSTRIELLES DÉPLOYABLES
Published on 06/18/2026 at 17:45, 12 hours 31 minutes ago ASSEMBLEE GENERALE DU 16 JUIN 2026 : COMPTE-RENDU ET RESULTATS DES VOTES
